beta blocker: be used in esophageal varices

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
be used in esophageal varices 1.00
be contraindicated in aortic stenosis 0.85
be called cystic fibrosis 0.84
be avoided in gastroesophageal reflux 0.84
be contraindicated in pulmonary edema 0.82
be contraindicated in stenosis 0.82
be used for myocardial infarction 0.82
be contraindicated in peripheral vascular disease 0.82
be contraindicated in vascular disease 0.82
cause pulmonary edema 0.81

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.49
Rule weight: 0.66
Evidence weight: 0.88
Similarity weight: 0.85
Evidence: 0.63
Plausible(vasodilator, be contraindicated in aortic stenosis) ⋁
Evidence: 0.34
¬ Typical(beta blocker, be used in esophageal varices)
0.45
Rule weight: 0.66
Evidence weight: 0.82
Similarity weight: 0.82
Evidence: 0.48
Plausible(vasodilator, be contraindicated in stenosis) ⋁
Evidence: 0.34
¬ Typical(beta blocker, be used in esophageal varices)
0.42
Rule weight: 0.66
Evidence weight: 0.79
Similarity weight: 0.81
Evidence: 0.37
Plausible(agent, cause pulmonary edema) ⋁
Evidence: 0.34
¬ Typical(beta blocker, be used in esophageal varices)
0.37
Rule weight: 0.66
Evidence weight: 0.67
Similarity weight: 0.84
Evidence: 0.03
Plausible(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.34
¬ Typical(beta blocker, be used in esophageal varices)

Plausibility inheritance from parent to child

0.08
Rule weight: 0.09
Evidence weight: 0.98
Similarity weight: 0.84
Evidence: 0.39
Plausible(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.03
¬ Plausible(agent, be avoided in gastroesophageal reflux)
0.06
Rule weight: 0.09
Evidence weight: 0.77
Similarity weight: 0.81
Evidence: 0.39
Plausible(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.37
¬ Plausible(agent, cause pulmonary edema)
0.05
Rule weight: 0.09
Evidence weight: 0.71
Similarity weight: 0.82
Evidence: 0.39
Plausible(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.48
¬ Plausible(vasodilator, be contraindicated in stenosis)
0.05
Rule weight: 0.09
Evidence weight: 0.61
Similarity weight: 0.85
Evidence: 0.39
Plausible(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.63
¬ Plausible(vasodilator, be contraindicated in aortic stenosis)

Remarkability exclusitivity betweem a parent and a child

0.47
Rule weight: 0.58
Evidence weight: 0.98
Similarity weight: 0.84
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.03
¬ Remarkable(agent, be avoided in gastroesophageal reflux)
0.39
Rule weight: 0.58
Evidence weight: 0.84
Similarity weight: 0.81
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.22
¬ Remarkable(agent, cause pulmonary edema)
0.23
Rule weight: 0.58
Evidence weight: 0.47
Similarity weight: 0.85
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.73
¬ Remarkable(vasodilator, be contraindicated in aortic stenosis)
0.19
Rule weight: 0.58
Evidence weight: 0.40
Similarity weight: 0.82
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.82
¬ Remarkable(vasodilator, be contraindicated in stenosis)

Remarkability exclusitivity between siblings

0.03
Rule weight: 0.13
Evidence weight: 0.30
Similarity weight: 0.84
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.95
¬ Remarkable(cystic fibrosis, be called cystic fibrosis)

Remarkability from parent implausibility

0.34
Rule weight: 0.42
Evidence weight: 0.96
Similarity weight: 0.85
Evidence: 0.63
Plausible(vasodilator, be contraindicated in aortic stenosis) ⋁
Evidence: 0.73
Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.39
¬ Plausible(beta blocker, be used in esophageal varices)
0.33
Rule weight: 0.42
Evidence weight: 0.95
Similarity weight: 0.82
Evidence: 0.48
Plausible(vasodilator, be contraindicated in stenosis) ⋁
Evidence: 0.73
Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.39
¬ Plausible(beta blocker, be used in esophageal varices)
0.32
Rule weight: 0.42
Evidence weight: 0.93
Similarity weight: 0.81
Evidence: 0.37
Plausible(agent, cause pulmonary edema) ⋁
Evidence: 0.73
Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.39
¬ Plausible(beta blocker, be used in esophageal varices)
0.32
Rule weight: 0.42
Evidence weight: 0.90
Similarity weight: 0.84
Evidence: 0.03
Plausible(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.73
Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.39
¬ Plausible(beta blocker, be used in esophageal varices)

Remarkability from sibling implausibility

0.50
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.84
Evidence: 0.39
Plausible(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.95
Remarkable(cystic fibrosis, be called cystic fibrosis) ⋁
Evidence: 0.36
¬ Plausible(cystic fibrosis, be called cystic fibrosis)

Salient implies Plausible

0.20
Rule weight: 0.28
Evidence weight: 0.70
Similarity weight: 1.00
Evidence: 0.39
Plausible(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.48
¬ Salient(beta blocker, be used in esophageal varices)

Similarity expansion

0.56
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.82
Evidence: 0.73
Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.75
¬ Remarkable(beta blocker, be contraindicated in pulmonary edema)
0.54
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.82
Evidence: 0.73
Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.84
¬ Remarkable(beta blocker, be used for myocardial infarction)
0.54
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.82
Evidence: 0.73
Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.83
¬ Remarkable(beta blocker, be contraindicated in peripheral vascular disease)
0.50
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.82
Evidence: 0.34
Typical(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.44
¬ Typical(beta blocker, be used for myocardial infarction)
0.47
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.82
Evidence: 0.39
Plausible(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.53
¬ Plausible(beta blocker, be used for myocardial infarction)
0.46
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.82
Evidence: 0.34
Typical(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.52
¬ Typical(beta blocker, be contraindicated in peripheral vascular disease)
0.45
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.82
Evidence: 0.39
Plausible(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.60
¬ Plausible(beta blocker, be contraindicated in pulmonary edema)
0.45
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.82
Evidence: 0.39
Plausible(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.59
¬ Plausible(beta blocker, be contraindicated in peripheral vascular disease)
0.44
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.82
Evidence: 0.48
Salient(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.72
¬ Salient(beta blocker, be used for myocardial infarction)
0.44
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.82
Evidence: 0.48
Salient(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.74
¬ Salient(beta blocker, be contraindicated in pulmonary edema)
0.44
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.82
Evidence: 0.34
Typical(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.58
¬ Typical(beta blocker, be contraindicated in pulmonary edema)
0.42
Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.82
Evidence: 0.48
Salient(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.78
¬ Salient(beta blocker, be contraindicated in peripheral vascular disease)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.48
Salient(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.34
¬ Typical(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.39
Plausible(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.34
¬ Typical(beta blocker, be used in esophageal varices)

Typicality and Rermarkability incompatibility between a parent and a child

0.36
Rule weight: 0.51
Evidence weight: 0.84
Similarity weight: 0.84
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.22
¬ Typical(agent, be avoided in gastroesophageal reflux)
0.30
Rule weight: 0.51
Evidence weight: 0.73
Similarity weight: 0.82
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.37
¬ Typical(vasodilator, be contraindicated in stenosis)
0.24
Rule weight: 0.51
Evidence weight: 0.55
Similarity weight: 0.85
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.61
¬ Typical(vasodilator, be contraindicated in aortic stenosis)
0.23
Rule weight: 0.51
Evidence weight: 0.57
Similarity weight: 0.81
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.59
¬ Typical(agent, cause pulmonary edema)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.91
Similarity weight: 0.84
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.12
¬ Typical(cystic fibrosis, be called cystic fibrosis)

Typicality inheritance from parent to child

0.35
Rule weight: 0.48
Evidence weight: 0.85
Similarity weight: 0.84
Evidence: 0.34
Typical(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.22
¬ Typical(agent, be avoided in gastroesophageal reflux)
0.30
Rule weight: 0.48
Evidence weight: 0.75
Similarity weight: 0.82
Evidence: 0.34
Typical(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.37
¬ Typical(vasodilator, be contraindicated in stenosis)
0.25
Rule weight: 0.48
Evidence weight: 0.60
Similarity weight: 0.85
Evidence: 0.34
Typical(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.61
¬ Typical(vasodilator, be contraindicated in aortic stenosis)
0.24
Rule weight: 0.48
Evidence weight: 0.61
Similarity weight: 0.81
Evidence: 0.34
Typical(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.59
¬ Typical(agent, cause pulmonary edema)